The Challenges of Clinical Trial Design in Evaluating HIV Antiretroviral Use in Heavily Pre-Treated Patients

The Community Perspective

Carlton Hogan, University of MN

FDA Antiviral Advisory Committee

January 11, 2001

Next slide

Back to first slide

View graphic version